A Scandinavian study including Finland, Sweden, Norway and Denmark found that men under the age of 30 who received Modern Spikevax were more likely to develop myocarditis than the controls, said Mika Salminen, director of the Finnish Institute of Health.

See: Sweden suspends Moderna vaccinations for people under 30 years old

Instead, he said, men born in 1991 and later would be recommended to administer the lotion developed by Pfizer/BioNTech. Earlier, a similar decision was made by Sweden, Denmark and Norway, which, although – unlike other Scandinavian countries – recommend only choosing the Comirnata vaccine in young people.

A spokesperson for Moderna said late Wednesday that it was aware of the regulators’ decisions. These are usually mild cases, and individuals tend to recover within a short period of time after usual treatment and rest. He said the risk of developing myocarditis increases dramatically in people with COVID-19, and vaccination is the best way to prevent it.

Symptoms to watch out for

In Sweden, from December 1, the Pfizer vaccine will be given to people born in 1991 and later.

See: Moderna’s contaminated vaccines in Japan. Decide on the “human factor”

According to the country’s chief epidemiologist, Anders Tegnell, “People who have already been vaccinated with one or two doses should not worry because the risk of side effects is very small.” – But it’s good to know what symptoms to look for – he emphasized.

As added, myocarditis usually goes away on its own, but it is worth consulting a doctor. Symptoms of the disease included: fatigue and shortness of breath, body pain and fever, irregular heartbeat and heart palpitations, pain and a feeling of heaviness in the chest.

rsr / PAP / Polsatnews.pl / Reuters

See also  In the US, infections reach a new high as the Australian state eases restrictions - as it happened | world News

Read more